Clinical trials portfolio and regulatory outcomes of ixazomib in multiple myeloma: A systematic review and meta-analysis
- Author(s)
- Shah, V; Shah, D; Utzman, P; Shah, K; Swaminathan, S; Mainou, M; Chakraborty, R; Goodman, A; Al Hadidi, S; Kelkar, AH; Cliff, ERS; Mohyuddin, GR;
- Journal Title
- British Journal of Haematology
- Publication Type
- Online publication before print
- Keywords
- drug development; drug regulation; ixazomib; me too drug; multiple myeloma; next in class drug; proteasome inhibitor
- Department(s)
- Haematology
- Publisher's Version
- https://doi.org/10.1111/bjh.70757
- Open Access at Publisher's Site
https://doi.org/10.1111/bjh.70757- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2026-09-14 05:56:13
Last Modified: 2026-09-14 05:56:18